BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30291566)

  • 1. Incomplete myelopathy and human T cell lymphotropic virus type-1 (HTLV-1).
    Koyama RVL; Yoshikawa GT; Fujihara S; da Silva Dias GA; Virgolino RR; Rodrigues AR; Medeiros R; Simões Quaresma JA; Fuzii HT
    J Neurovirol; 2019 Feb; 25(1):1-8. PubMed ID: 30291566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Balance Impairments in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection.
    Vasconcelos BHB; Callegari B; Costa KHA; Barroso TGCP; Sousa RCM; Saunier G; Xavier MB; Souza GS
    Sci Rep; 2019 Aug; 9(1):11456. PubMed ID: 31391511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T helper type 9 cell response and its role in the neurological clinic of patients with Human T-lymphotropic virus 1.
    de Sena Rodrigues Júnior R; Antonia Nunes Gomes J; Alberto da Silva Dias G; Fujihara S; Toshimitsu Yoshikawa G; Vilela Lopes Koyama R; Catarina Medeiros Sousa R; Antonio Simões Quaresma J; Thais Fuzii H
    Immunobiology; 2023 Nov; 228(6):152740. PubMed ID: 37657359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological manifestations in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis in the Amazon.
    Dias GA; Yoshikawa GT; Koyama RV; Fujihara S; Martins LC; Medeiros R; Quaresma JA; Fuzii HT
    Spinal Cord; 2016 Feb; 54(2):154-7. PubMed ID: 26169165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
    Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
    J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
    Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
    Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
    Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Nakamura T; Nishiura Y; Eguchi K
    Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):137-49. PubMed ID: 20021347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations.
    Matsuzaki T; Nakagawa M; Nagai M; Nobuhara Y; Usuku K; Higuchi I; Takahashi K; Moritoyo T; Arimura K; Izumo S; Akiba S; Osame M
    J Neurovirol; 2000 Dec; 6(6):544-8. PubMed ID: 11175327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-presentation of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis and adult-onset infective dermatitis associated with HTLV-1 infection.
    Okajima R; Casseb J; Sanches JA
    Int J Dermatol; 2013 Jan; 52(1):63-8. PubMed ID: 23278610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
    Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
    Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vestibular-evoked myogenic potential (VEMP) to evaluate cervical myelopathy in human T-cell lymphotropic virus type I infection.
    Felipe L; Gonçalves DU; Santos MA; Proietti FA; Ribas JG; Carneiro-Proietti AB; Lambertucci JR
    Spine (Phila Pa 1976); 2008 May; 33(11):1180-4. PubMed ID: 18469690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM/TSP: what is its relevance as a prognostic marker for neurologic disease?
    Martins ML; Guimarães JC; Ribas JG; Romanelli LC; de Freitas Carneiro-Proietti AB
    J Neurovirol; 2017 Feb; 23(1):125-133. PubMed ID: 27678093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tax secretion from peripheral blood mononuclear cells and Tax detection in plasma of patients with human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis and asymptomatic carriers.
    Medina F; Quintremil S; Alberti C; Godoy F; Pando ME; Bustamante A; Barriga A; Cartier L; Puente J; Tanaka Y; Valenzuela MA; Ramírez E
    J Med Virol; 2016 Mar; 88(3):521-31. PubMed ID: 26241614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
    Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
    Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
    Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
    J Med Virol; 2012 Feb; 84(2):319-26. PubMed ID: 22170554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil.
    Schor D; Porto LC; Roma EH; Quintana MSB; Fabricio-Silva GM; Bonecini-Almeida MG; Araújo AQ; Andrada-Serpa MJ
    BMC Infect Dis; 2018 Nov; 18(1):593. PubMed ID: 30466392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of clinical and neurological signs in apparently asymptomatic HTLV-1 infected carriers: Association with high proviral load.
    Haziot ME; Gascon MR; Assone T; Fonseca LAM; Luiz ODC; Smid J; Paiva AM; Marcusso RMDN; de Oliveira ACP; Casseb J
    PLoS Negl Trop Dis; 2019 May; 13(5):e0006967. PubMed ID: 31042700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.